Epidemiology of and risk factors for invasive aspergillosis in nonneutropenic patients;Épidémiologie et facteurs de risque de l'aspergillose invasive du sujet non neutropénique

Revue des Maladies Respiratoires

Volumn 25, Issue 2, 2008, Pages 139-153

  Gangneux, J P ^a   Camus, C ^a   Philippe, B ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Aspergillus fumigatus; Immunosuppressive therapy; Invasive aspergillosis; Nonneutropenic patients; Solid organ transplantation

Indexed keywords

CORTICOSTEROID; FLUCONAZOLE; INFLIXIMAB; OKT 3; RAPAMYCIN;

ASPERGILLUS FUMIGATUS; CHRONIC RESPIRATORY TRACT DISEASE; DISEASE CLASSIFICATION; HUMAN; LUNG ASPERGILLOSIS; MORBIDITY; NEUTROPENIA; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYSTEMIC DISEASE; IMMUNE DEFICIENCY; OPPORTUNISTIC INFECTION;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; HUMANS; IMMUNOCOMPROMISED HOST; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 44349160082     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)71512-2     Document Type: Review

References (140)

1. Latge JP : Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999 ; 12 : 310-50.
2. Marr KA, Patterson T, Denning D : Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002 ; 16 : 875-94.
3. Marr KA, Bowden RA. Fungal infections in patients undergoing blood and marrow transplantation. Transpl Infect Dis 1999 ; 1 : 237-46.
4. Paterson DL, Singh N : Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999 ; 78 : 123-38.
5. Singh N, Paterson DL : Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005 ; 18 : 44-69.
6. Denning DW, Riniotis K, Dobrashian R, Sambatakou H : Chronic cavitary and fibrosing pulmonary and pleural aspergillosis : case series, proposed nomenclature change, and review. Clin Infect Dis 2003 ; 37 : S265-80.
7. Ader F, Nseir S, Tillie-Leblond I, Guery B : Aspergillose pulmonaire aiguë invasive et pathologies pulmonaires chroniques. Rev Mal Respir 2006 ; 23 : 6S11-20.
8. Trof RJ, Beishuizen A, Debets-Ossenkopp, Girbes ARJ, Groeneveld ABJ : Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med 2007 ; 33 : 1694-703.
9. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupee M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP : Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients : a 6-year survey. Clin Infect Dis 2006 ; 43 : 577-84.
10. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E : Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004 ; 170 : 621-5.
11. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL : Disseminated aspergillosis in intensive care unit patients : an autopsy study. J Chemother .2003 ; 15 : 71-5.
12. Marcq M, Germaud P, Cellerin L, Sagan C, Chailleux E : Aspergilloses respiratoires complexes : difficultés diagnostiques et thérapeutiques. Rev Mal Respir 2004 ; 21 : 1162-6.
13. Philippe B, Ibrahim-Granet O, Prevost MC, Gougerot-Pocidalo MA, Sanchez Perez M, Van der Meeren A, Latge JP : Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003 ; 71 : 3034-42.
14. Montagnoli C, Fallarino F, Gaziano R, Bozza S, Bellochio S, Zelante T, Kurup WP, Pitzurra L, Puccetti P, Romani L : Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 2006 ; 176 : 1712-23.
15. Bakare N, Rickerts V, Bargon J, Just-Nubling G : Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003 ; 46 : 19-23.
16. Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, Strandvik B, McKenzie SG : Factors associated with poor pulmonary function : cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2001 ; 18 : 298-305.
17. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G : Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art : cystic fibrosis foundation consensus conference. Clin Infect Dis 2003 ; 37 : S225-64.
18. Maguire C, Hayes J, Hayes M, Masterson J, FitzGerald M : Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis. Thorax 1995 ; 50 : 805-6.
19. Logan M, McLoughlin R, Gibney RG : Aspergilloma complicating cystic fibrosis. AJR Am J Roentgenol 1993 ; 161 : 674-5.
20. Brown K, Rosenthal M, Bush A : Fatal invasive aspergillosis in an adolescent with cystic fibrosis. Pediatr Pulmonol 1999 ; 27 : 130-3.
21. Brenier-Pinchart MP, Lebeau B, Devouassoux G, Mondon P, Pison C, Ambroise-Thomas P, Grillot R : Aspergillus and lung transplant recipients : a mycologic and molecular epidemiologic study. J Heart Lung Transplant 1998 ; 17 : 972-9.
22. Hamacher J, Spiliopoulos A, Kurt AM, Nicod LP : Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group. Eur Respir J 1999 ; 13 : 180-6.
23. Nunley DR, Ohori P, Grgurich WF, Iacono AT, Williams PA, Keenan RJ, Dauber JH : Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998 ; 114 : 1321-9.
24. Paradowski LJ. Saprophytic fungal infections and lung transplantation--revisited. J Heart Lung Transplant 1997 ; 16 : 524-31.
25. Westney GE, Kesten S, De Hoyos A, Chapparro C, Winton T, Maurer JR : Aspergillus infection in single and double lung transplant recipients. Transplantation 1996 ; 61 : 915-9.
26. Cahill BC, Hibbs JR, Savik K, Juni BA, Dosland BM., Edin-Stibbe C, Hertz MI : Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997 ; 112 : 1160-4.
27. Yeldandi V, Laghi F, McCabe MA, Larson R, O’Keefe P, Husain A, Montoya A, Garrity ER Jr : Aspergillus and lung transplantation. J Heart Lung Transplant 1995 ; 14 : 883-90.
28. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR : Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994 ; 149 : 1601-7.
29. rd Spectrum of Aspergillus infection in lung transplant recipients : case series and review of the literature. Chest 2001 ; 119 : 169-75.
30. Paterson DL : New clinical presentations of invasive aspergillosis in non-conventional hosts. Clin Microbiol Infect 2004 ; 10 1 : 24-30.
31. Gilbey JG, Chalermskulrat W, Aris RM : Aspergillus endocarditis in a lung transplant recipient. A case report and review of the transplant literature. Ann Transplant 2000 ; 5 : 48-53.
32. Chaparro C, Maurer JR, Chamberlain D, De Hoyos A, Winton T, Westney G, Kesten S : Causes of death in lung transplant recipients. J Heart Lung Transplant 1994 ; 13 : 758-66.
33. Venuta F, Boehler A, Rendina EA, De Giacomo T, Speich R, Schmid R, Coloni GF, Weder W : Complications in the native lung after single lung transplantation. Eur J Cardiothorac Surg 1999 ; 16 : 54-8.
34. Horvath J, Dummer S, Loyd J, Walker B, Merrill WH, Frist WH : Infection in the transplanted and native lung after single lung transplantation. Chest 1993 ; 104 : 681-5.
35. Sandur S, Gordon SM, Mehta AC, Maurer JR : Native lung pneumonectomy for invasive pulmonary aspergillosis following lung transplantation : a case report. J Heart Lung Transplant 1999 ; 18 : 810-3.
36. Speziali G, McDougall JC, Midthun DE, Peters SG, Scott JP, Daly RC, McGregor CG : Native lung complications after single lung transplantation for emphysema. Transpl Int 1997 ; 10 : 113-5.
37. Stewart S, McNeil K, Nashef SA, Wells FC, Higenbottam TW, Wallwork J : Audit of referral and explant diagnoses in lung transplantation : a pathologic study of lungs removed for parenchymal disease. J Heart Lung Transplant 1995 ; 14 : 1173-86.
38. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G : Epidemiology of invasive aspergillosis in France : a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002 ; 51 : 288-96.
39. Montoya JG, Chaparro SV, Celis D, Cortes JA, Leung AN, Robbins RC, Stevens DA : Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis 2003 ; 37 : S281-92.
40. Panackal AA, Dahlman A, Keil KT, Peterson CL, Mascola L, Mirza S, Phelan M, Lasker BA, Brandt ME, Carpenter J, Bell M, Warnock DW, Hajjeh RA, Morgan J : Outbreak of invasive aspergillosis among renal transplant recipients. Transplantation 2003 ; 75 : 1050-3.
41. Singh N : Antifungal prophylaxis for solid organ transplant recipients : seeking clarity amidst controversy. Clin Infect Dis 2000 ; 31 : 545-53.
42. Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, Tollemar JG, Dominguez EA, Yu CM, Paterson DL, Husain S, Kusne S, Linden P : Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003 ; 36 : 46-52.
43. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH Jr : Invasive aspergillosis in renal transplant recipients : correlation with corticosteroid therapy. J Infect Dis 1983 ; 148 : 230-8.
44. Stuck AE, Minder CE, Frey FJ : Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989 ; 11 : 954-63.
45. McGowan JE Jr, Chesney PJ, Crossley KB, LaForce FM : Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J Infect Dis 1992 ; 165 : 1-13.
46. Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS : Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1983 ; 198 : 622-9.
47. Kusne S, Torre-Cisneros J, Manez R, Irish W, Martin M, Fung J, Simmons RL, Starzl TE : Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992 ; 166 : 1379-83.
48. Brown RS Jr, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP : Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation 1996 ; 61 : 666-9.
49. Munoz P, Alcala L, Sanchez Conde M, Palomo J, Yanez J, Pelaez T, Bouza E : The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation 2003 ; 75 : 326-9
50. van Burik JA, Colven R, Spach H : Cutaneous aspergillosis. J Clin Microbiol 1998 ; 36 : 3115-21.
51. Singh N : Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003 ; 17 : 113-34.
52. Fortun J, Martin-Davila P, Moreno S, De Vicente E, Nuno J, Candelas A, Barcena R, Garcia M : Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002 ; 8 : 1065-70.
53. Kontoyiannis DP : Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts : an alternative hypothesis. Clin Infect Dis 2002 ; 34 : 1281-3.
54. Simon DM, Levin S : Infectious complications of solid organ transplantations. Infect Dis Clin North Am 2001 ; 15 : 521-49.
55. Delmas Y, Merville P, Dousset V, Dervau-Durieux L, Morel D, Potaux L : A renal transplant recipient with acute paraparesis due to an Aspergillus epidural abscess. Nephrol Dial Transplant 1997 ; 12 : 2185-7.
56. Bonham CA, Dominguez EA, Fukui MB, Paterson DL, Pankey GA, Wagener MM, Fung JJ, Singh N : Central nervous system lesions in liver transplant recipients : prospective assessment of indications for biopsy and implications for management. Transplantation 1998 ; 66 : 1596-604.
57. Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L : Infections in heart transplant recipients : the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. J Heart Lung Transplant 1992 ; 11 : 847-66.
58. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS : Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987 ; 106 : 209-16.
59. Greenbaum RS, Roth JS, Grossman ME : Subcutaneous nodule in a cardiac transplant. Cutaneous aspergillosis. Arch Dermatol 1993 ; 129 : 1191-4.
60. Loria KM, Salinger MH, Frohlich TG, Gendelman MD, Cook FV, Arentzen CE : Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole. Heart Lung Transplant 1992 ; 11 : 156-9.
61. Ioannidis JP, Snydman DR, Rohrer RJ, Freeman RB, Haug CE : Aspergillus fumigatus infection of a biloma. Clin Infect Dis 1995 ; 20 : 1427-8.
62. Singh N, Arnow PM, Bonham A, Dominguez E, Paterson DL, Pankey GA, Wagener MM, Yu VL : Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997 ; 64 : 716-20.
63. Durand F, Bernuau J, Dupont B, Sauvanet A, Belghiti J, Degott C, Benhamou JP : Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole. Transplantation 1992 ; 54 : 734-5.
64. Pla MP, Berenguer J, Arzuaga JA, Banares R, Polo JR, Bouza E : Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn Microbiol Infect Dis 1992 ; 15 : 703-6.
65. Papanicolaou GA, Meyers BR, Fuchs WS, Guillory SL, Mendelson MH, Sheiner P, Emre S, Miller C : Infectious ocular complications in orthotopic liver transplant patients. Clin Infect Dis 1997 ; 24 : 1172-7.
66. Hadaya K, Akposso K, Costa de Beauregard MA, Haymann JP, Rondeau E, Sraer JD : Isolated urinary aspergillosis in a renal transplant recipient. Nephrol Dial Transplant 1998 ; 13 : 2382-4.
67. Shirwany A, Sargent SJ, Dmochowski RR, Bronze MS : Urinary tract aspergillosis in a renal transplant recipient. Clin Infect Dis 1998 ; 27 : 1336.
68. Singer AJ, Kubak B, Anders KH : Aspergillosis of the testis in a renal transplant recipient. Urology 1998 ; 51 : 119-21.
69. Kim SW, Nah MY, Yeum CH, Kim NH, Choi HS, Juhng SW, Choi KC : Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient. J Infect 2001 ; 42 : 215-7.
70. Cassuto-Viguier E, Mondain JR, Van Elslande L, Bendini JC, Gaid H, Franco M, Gari-Toussaint M : Fatal outcome of Aspergillus fumigatus arthritis in a renal transplant recipient. Transplant Proc 1995 ; 27 : 2461.
71. Le Conte P, Blanloeil Y, Germaud P, Morin O, Moreau P : [Invasive aspergillosis in intensive care]. Ann Fr Anesth Reanim 1995 ; 14 : 198-208.
72. Lionakis MS, Kontoyiannis DP : Glucocorticoids and invasive fungal infections. Lancet 2003 ; 362 : 1828-38.
73. Garrett DO, Jochimsen E, Jarvis W : Invasive Aspergillus spp infections in rheumatology patients. J Rheumatol 1999 ; 26 : 146-9.
74. Kim WU, Kim SI, Yoo WH, Park JH, Min JK, Kim SC, Hong YS, Lee SH, Park SH, Cho CS, Kim HY : Adult respiratory distress syndrome in systemic lupus erythematosus : causes and prognostic factors : a single center, retrospective study. Lupus 1999 ; 8 : 552-7.
75. Iriya SM, Capelozzi VL, Calich I, Martins MA, Lichtenstein A : Causes of death in patients with systemic lupus erythematosus in Sao Paulo, Brazil : a study of 113 autopsies. Arch Intern Med 2001 ; 161 : 1557.
76. Nenoff P, Horn LC, Mierzwa M, Leonhardt R, Weidenbach H, Lehmann I, Haustein UF : Peracute disseminated fatal Aspergillus fumigatus sepsis as a complication of corticoid-treated systemic lupus erythematosus. Mycoses 1995 ; 38 : 467-71.
77. O’Reilly S, Hartley P, Jeffers M, Casey E, Clancy L : Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis : a case report of treatment with itraconazole. Tuber Lung Dis 1994 ; 75 : 153-5.
78. Wiggins RE Jr : Invasive aspergillosis. A complication of treatment of temporal arteritis. J Neuroophthalmol 1995 ; 15 : 36-8.
79. Cleri DJ, Moser RL, Villota FJ, Wang Y, Husain SA, Nadeem S, Anjari T, Sajed M : Pulmonary aspergillosis and central nervous system hemorrhage as complications of autoimmune hemolytic anemia treated with corticosteroids. South Med J 2003 ; 96 : 592-5.
80. Scalzini A, Barni C, Stellini R, Sueri L : Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn’s disease. Dig Dis Sci 1995 ; 40 : 528.
81. De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE : Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody : a possible healthcare-associated case? Infect Control Hosp Epidemiol 2003 ; 24 : 477-82.
82. Warris A, Bjorneklett A, Gaustad P : Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001 ; 344 : 1099-100.
83. Mylonakis E, Barlam TF, Flanigan T, Rich JD : Pulmonary aspergillosis and invasive disease in AIDS : review of 342 cases. Chest 1998 ; 114 : 251-62.
84. Libanore M, Prini E, Mazzetti M, Barchi E, Raise E, Gritti FM, Bonazzi L, Ghinelli F : Invasive Aspergillosis in Italian AIDS patients. Infection 2002 ; 30 : 341-5.
85. Stone HH, Cuzzell JZ, Kolb LD, Moskowitz MS, McGowan JE Jr : Aspergillus infection of the burn wound. J Trauma 1979 ; 19 : 765-7.
86. Williams G, Moiemen N, Frame JD : Aspergillosis presenting as Koebner’s phenomenon in a healed scald. Burns 2000 ; 26 : 92-6.
87. Letscher V, Herbrecht R, Gaudias J, Taglang G, Koenig H, Dupuis MG, Waller J : Post-traumatic intracranial epidural Aspergillus fumigatus abscess. J Med Vet Mycol 1997 ; 35 : 279-82.
88. Morioka T, Tashima T, Nagata S, Fukui M, Hasuo K : Cerebral aspergillosis after burr-hole surgery for chronic subdural hematoma : case report. Neurosurgery 1990 ; 26 : 332-5.
89. Vandecasteele SJ, Boelaert JR, Verrelst P, Graulus E, Gordts BZ : Diagnosis and treatment of Aspergillus flavus sternal wound infections after cardiac surgery. Clin Infect Dis 2002 ; 35 : 887-90.
90. Kowacs PA, Monteiro de Almeida S, Pinheiro RL, Fameli H, Piovesan EJ, Correia A, Werneck LC : Central nervous system Aspergillus fumigatus infection after near drowning. J Clin Pathol 2004 ; 57 : 202-4.
91. Vieira DF, Van Saene HK, Miranda DR : Invasive pulmonary aspergillosis after near-drowning. Intensive Care Med 1984 ; 10 : 203-4.
92. Pierrotti LC, Baddour LM : Fungal endocarditis, 1995-2000. Chest 2002 ; 122 : 302-10.
93. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W : Fungal endocarditis : evidence in the world literature, 1965-1995. Clin Infect Dis 2001 ; 32 : 50-62.
94. Gumbo T, Taege AJ, Mawhorter S, McHenry MC, Lytle BH, Cosgrove DM, Gordon SM : Aspergillus valve endocarditis in patients without prior cardiac surgery. Medicine (Baltimore) 2000 ; 79 : 261-8.
95. Chambers J, Blauth C, Bucknall C, Eykyn S : Images in clinical medicine. Aspergilloma as a complication of pacemaker implantation. N Engl J Med 2002 ; 346 : 428.
96. Cisneros JM, Munoz P, Torre-Cisneros J, Gurgui M, Rodriguez-Hernandez MJ, Aguado JM, Echaniz A : Pneumonia after heart transplantation : a multi-institutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis 1998 ; 27 : 324-31.
97. Bretagne S, Costa JM, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C : Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998 ; 26 : 1407-12.
98. Uffredi ML, Mangiapan G, Cadranel J, Kac G : Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients. Eur J Clin Microbiol Infect Dis 2003 ; 22 : 457-62.
99. Hearn VM, Pinel C, Blachier S, Ambroise-Thomas P, Grillot R : Specific antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methods. J Clin Microbiol 1995 ; 33 : 982-6.
100. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Eldere J, Verbist L, Boogaerts M : Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 1999 ; 37 : 3223-8.
101. 101. Sulahian A, Tabouret M, Ribaud P, Sarfati J, Gluckman E, Latge JP, Derouin F : Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996 ; 15 : 139-45.
102. Mennink-Kersten MA, Donnelly JP, Verweij PE : Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004 ; 4 : 349-57.
103. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ : Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis : variables that affect performance. J Infect Dis 2004 ; 190 : 641-9.
104. Hope WW, Walsh TJ, Denning DW : Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005 ; 5 : 609-22.
105. Bart-Delabesse E, Basile M, Al Jijakli A, Souville D, Gay F, Philippe B, Bossi P, Danis M, Vernant JP, Datry A : Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005 ; 43 : 5214-20.
106. Sulahian A, Touratier S, Ribaud P : False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003 ; 349 : 2366-7.
107. Mennink-Kersten MA, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJ, Verweij PE : Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol 2005 ; 43 : 3925-31.
108. Gangneux JP, Lavarde D, Bretagne S, Guiguen C, Gandemer V : Transient Aspergillus antigenaemia : think of milk. Lancet 2002 ; 359 : 1251.
109. Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener MM, Singh N : Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004 ; 42 : 435-8.
110. Cornet M, Mallat H, Somme D, Guerot E, Kac G, Mainardi JL, Fornes P, Gutmann L, Lavarde V : Fulminant invasive pulmonary aspergillosis in immunocompetent patients--a two-case report. Clin Microbiol Infect 2003 ; 9 : 1224-7.
111. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E : Galactomannan in broncho-alveolar lavage fluid : a tool for diagnosing aspergillosis in ICU patients. Am J Respir Crit Care Med 2007 [Epub ahead of print].
112. Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Baz M, Rand KH, Clancy CJ : Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 2007 ; 45 : 2787-92.
113. Patterson TF : Approaches to fungal diagnosis in transplantation. Transpl Infect Dis 1999 ; 1 : 262-72.
114. Oner-Eyuboglu F, Karacan O, Akcay S, Arslan H, Demirhan B, Haberal M : Invasive pulmonary fungal infections in solid organ transplant recipients : a four-year review. Transplant Proc 2003 ; 35 : 2689-91.
115. Caillot D, Mannone L, Cuisenier B, Couaillier JF : Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect 2001 ; 7 : 54-61.
116. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ : Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants : an international consensus. Clin Infect Dis 2002 ; 34 : 7-14.
117. Wingard JR, Kubilis P, Lee L, Yee G, White M, Walshe L, Bowden R, Anaissie E, Hiemenz J, Lister J : Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 1999 ; 29 : 1402-7.
118. Linden PK, Coley K, Fontes P, Fung JJ, Kusne S : Invasive aspergillosis in liver transplant recipients : outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin Infect Dis 2003 ; 37 : 17-25.
119. Wingard JR, White MH, Anaissie E, Raffalli J, Goodman J, Arrieta A : A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group. Clin Infect Dis 2000 ; 31 : 1155-63.
120. Ellis M, Spence D, de Pauw B, Meunier F, Marinus A, Collette L, Sylvester R, Meis J, Boogaerts M, Selleslag D, Krcmery V, von Sinner W, MacDonald P, Doyen C, Vandercam B : An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Clin Infect Dis 1998 ; 27 : 1406-12.
121. Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, Graybill JR, Sugar AM, Catanzaro A, and NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med 1994 ; 97 : 135-44.
122. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B : Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002 ; 347 : 408-15.
123. Singh N, Limaye AP, Forrest G, Safdar N, Munoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S : Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients : a prospective, multicenter, observational study. Transplantation 2006 ; 81 : 320-6.
124. Romero AJ, Pogamp PL, Nilsson LG, Wood N : Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients. Clin Pharmacol Ther 2002 ; 71 : 226-34.
125. Venkataramanan R, Zang S, Gayowski T, Singh N : Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother 2002 ; 46 : 3091-3.
126. Pai MP, Allen S : Voriconazole inhibition of tacrolimus metabolism. Clin Infect Dis 2003 ; 36 : 1089-91.
127. Keating GM : Posaconazole. Drugs 2005 ; 65 : 1553-67.
128. Duchini A, Redfield DC, McHutchison JG, Brunson ME, Pockros PJ : Aspergillosis in liver transplant recipients : successful treatment and improved survival using a multistep approach. South Med J 2002 ; 95 : 897-9.
129. Utili R, Zampino R, De Vivo F, Maiello C, Andreana A, Mormone G, Marra C, Tripodi MF, Sarnataro G, Cione P, Cuccurullo S, Cotrufo M : Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. Clin Transplant 2000 ; 14 : 282-6.
130. Garcia A, Mazuecos A, Clayo A, Perez-Requena J, Mangas A, Alonso F, Ceballos M, Rivero M : Isolated cerebral aspergillosis without a portal of entry--complete recovery after liposomal amphotericin B and surgical treatment. Nephrol Dial Transplant 1998 ; 13 : 2385-7.
131. Carlini A, Angelini D, Burrows L, De Quirico G, Antonelli A : Cerebral aspergillosis : long term efficacy and safety of liposomal amphotericin B in kidney transplant. Nephrol Dial Transplant 1998 ; 13 : 2659-61.
132. Avery RK : Prophylactic strategies before solid-organ transplantation. Curr Opin Infect Dis 2004 ; 17 : 353-6.
133. Gordon SM, Avery RK : Aspergillosis in lung transplantation : incidence, risk factors, and prophylactic strategies. Transpl Infect Dis 2001 ; 3 : 161-7.
134. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D : Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007 ; 356 : 348-59.
135. Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S : Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007 ; 356 : 335-47.
136. Glasmacher A, Prentice A, Gorschluter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG : Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies : evidence from a meta-analysis of 3, 597 patients. J Clin Oncol 2003 ; 21 : 4615-26
137. Marr KA, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee SA, Nichols WG, Musher B, Corey L : Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004 ; 103 : 1527-33.
138. Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA,Warnock DW : A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol 1999 ; 105 : 901-11.
139. Munoz P, Rodriguez C, Bouza E, Palomo J, Yanez JF, Dominguez MJ, Desco M : Risk factors of invasive aspergillosis after heart transplantation : protective role of oral itraconazole prophylaxis. Am J Transplant 2004 ; 4 : 636-43.
140. Fortun J, Martin-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, Garcia M, Nuno J, Candela A, Uriarte M, Pintado V : Prevention of invasive fungal infections in liver transplant recipients : the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003 ; 52 : 813-9.